|
|
||||||||
| ABSTRACT |
|
|
|---|
| INTRODUCTION |
|
|
|---|
receptors, and consequently a higher viremia is observed.3 Although widely accepted, it is not clear how higher viremia levels cause the pathology and symptoms of DHF. A high level of different cytokines produced both by dengue virus-infected monocytes and activated specific T lymphocytes could explain the main manifestation of DHF, plasma leakage.4 A shift from a Th1-dominant response to a Th2-biased response has been proposed by some as a mechanism of DHF.5 Recently, Mongkolsapaya and others proposed that profound T cell activation and death by apoptosis may contribute to the systemic disturbances leading to DHF, and that "original antigenic sin" of T cells occurs, suppressing or delaying virus elimination.6 Despite these new findings, the basic molecular mechanisms leading to DHF are not defined. During immune activation by viral entities, neutrophils and others cells produce reactive oxygen species (ROS) as a mechanism of signal amplification for protection.7 Endothelial cell growth, death, and functions are important determinants of vascular homeostasis. Although the role of in promoting endothelial dysfunction and death has been well studied, the role of endogenously generated ROS in endothelial cell survival is relatively unknown. Research on the relationship between ROS and vascular dysfunction originated in a report in 1981 by Granger and others.8 Additional data were later provided by Irani.9
Oxidative stress initiates and regulates the transcription and activation of a large series of others mediators in cells, which culminate in common mechanism of damage: apoptosis, necrosis, inflammation, immune response, ischemia, vasculitis, altered gene expression, and regeneration. The prevalence and the persistence of one or more of these aspects may influence the occurrence of different types of diseases.10
Oxygen-centered free radicals and others chemical species, often referred to as ROS, are well known as oxidants. The ROS have been recognized as widespread mediators both of cell injury and either intercellular or intracellular signaling processes. They are formed by several physiologic processes, but are currently thought to be involved in the pathogenesis of several disorders, sometimes as causes, sometimes as effects.11
Oxidative stress arises when the balance between oxidants and antioxidants is tipped in favor of the former.12 This phenomenon may be influenced by exogenous agents but also by endogenous ones such as viruses. There is now much evidence that oxidants play a complex role in viral diseases, starting from influences on host cell metabolism and viral replication and extending to desirable inactivating effects on viruses and less desired toxic effects on host tissue.13,14 Recently, several approaches to study antioxidant consumption and markers of free radical-induced damage have been described. Oxidative damage may affect all biochemical compounds including lipids, proteins, nucleic acids, carbohydrates, and macromolecules of connective tissue.15 This process might causes the loss of fluidity, leads to the destruction of cell membrane because of structural deformity and the production of lipoperoxides and their products, such as malondialdehyde (MDA) and 4-hydroxyalkenals (4-HDA). Inactivation and removal of these ROS depend on relations involving a wide spectrum of antioxidative defense mechanisms.16
The capacity of defense is determined by a dynamic interaction between individual components, which comprises vitamins and metabolites such as glutathione (GSH) and antioxidant enzymes. Among these enzymes, the most important are superoxide dismutase (SOD) and glutathione peroxidase (GPx). Malondialdehyde is the most abundant aldehyde generated by the attack of free radicals on polyunsaturated fatty acids of cell membranes. It should be noted that total hydroperoxides (THs) are not only passive markers of oxidizing stress, but are also cytotoxic products that could modify DNA and proteins.16
While alterations of redox status have been observed in several viral diseases such as acquired immunodeficiency syndrome, hepatitis C, bronchitis, pneumonia (influenza virus),17 and lymphoma (human T lymphotropic virus type I),18 they have not been reported during a dengue infection. The aim of this investigation was to study the status of some oxidative stress markers in serologically confirmed adult dengue patients comparing with those observed in healthy individuals.
| METHODS |
|
|
|---|
Informed consent was obtained from patients after they were given a verbal and written explanation of the objectives and risks of the study. Procedures were previously reviewed and approved by the Committee for Research on Human Subjects of the Pedro Kourí Tropical Medicine Institute.
Controls included 22 sex- and age-matched healthy individuals. Oxidative stress indices in controls were used to compare those in dengue patients. Serum samples of both patients and controls were stored at 70°C until analysis.
Total antioxidant status (TAS). For TAS quantitation, a commercial kit (catalog no. NX2332; Randox, Ltd., Crumlin, United Kingdom) was used. Briefly, ABTS (2,2'-azino-di-(3-ethylbenzthiazoline sulfonate) was incubated with metmyoglobin and hydrogen peroxide to produce the radical cation ABTS+. This has a relatively stable blue-green color that can be measured at 600 nm. Based on their concentration, antioxidants will cause a suppression of the color production.2325
Peroxidation potential (PP). For the determination of the susceptibility to lipid peroxidation, serum samples were incubated with a solution of cupric sulfate (final concentration = 2 mM) at 37°C for 24 hours. The PP was calculated by subtracting the MDA concentration at time 0 from the one obtained at 24 hours.26
Glutathione. Serum reduced GSH was analyzed with the method described by Sedlak and Lindsay.27 Glutathione (Sigma, St. Louis, MO) was used to generate the standard curves.
Glutathione peroxidase. Evaluation of GPx activity was determined using a commercial kit (catalog no. RS505; Randox, Ltd.). Briefly, GPx catalyzes the oxidation of GSH by cumene hydroperoxide. In the presence of GSH reductase and NADPH, the oxidized GSH is immediately converted to the reduced form with a concomitant oxidation of NADPH to NADP+. The decrease in absorbance at 340 nm is measured.24
Superoxide dismutase. Evaluation of SOD activity was determined using a commercial kit (catalog no. SD125; Randox, Ltd.). Briefly, this method uses xanthine and xanthine oxidase to generate superoxide radicals, which reacts with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltretazolium chloride to form a red formazan dye. The SOD activity is then measured by the inhibition of this reaction.24
Total hydroperoxides (THs). The THs were measured with a commercial assay (Bioxytech H2O2-560 kit catalog no. 21024; (Oxis International, Inc., Portland, OR). The assay is based on the oxidation of ferrous ions to ferric ions by hydroperoxides under acidic conditions. Ferric ions bind with the indicator dye xylenol orange (3,3'-bis(N,N-di(carboxymethyl)-aminomethyl)-o-cresolsulfone-phatein, sodium salt) to form a stable colored complex that can be measured at 560 nm.23
Malondialdehyde and 4-hydroxyalkenal concentration. The MDA + 4-HAD concentrations were analyzed with a commercial kit (LPO-586; Calbiochem, La Jolla, CA). In this assay, stable chromophore production after incubation for 40 minutes at 45°C is measured at 586 nm using a Pharmacia (Piscataway, NJ) spectrophotometer. Lipid peroxidation was expressed as the normalized content of MDA + 4-HDA. Values were expressed in nanomoles.28
Unless otherwise stated, all chemicals were obtained from Sigma.
Statistical analysis. Oxidative stress indices are given as the mean ± SEM. Analysis of variance and comparison of means were performed to detect significant differences between controls and cases at days 3, 5 and 7 using an unpaired t-test for non-parametric variables (Kruskall-Wallis test). Statistical significance was defined as P < 0.05. Analysis was done using SPSS version 10.0 software (SPSS, Inc., Chicago, IL).
| RESULTS |
|
|
|---|
|
|
| DISCUSSION |
|
|
|---|
In this investigation, we demonstrated a redox status alteration in the sera of dengue patients. To our knowledge, this is the first study documenting an increase in lipid peroxidation with a pro-oxidant state, a reduced antioxidant activity of GPx, an increase in SOD activity, and a low antioxidant capacity evaluated as PP during an infection with dengue virus. This finding is consistent with another report of increased oxidant and lowered antioxidative serum capacity associated with viral illness.13
The levels of hydrophilic and lipophilic antioxidants were measured in serum samples collected at three different times during the acute phase of the disease. The PP was significantly high in dengue patients compared with controls. In contrast, TAS was similar in both groups except at day 7 after the onset of fever. The higher PP values found in our patients suggest a decrease in lipid scavenger species or an increase in ROS generation. The dramatic increase of the byproduct of lipid peroxidation (MDA + 4-HDA) is consistent with a previous observation that showed the disruption of the redox balance.29
Antioxidant enzyme levels are sensitive to oxidative stress. Both increased and decreased levels have been reported in different diseases in which an enhancement of ROS is a cause or a consequence of the illness.30 In this study, we observed a decrease in GPx and an increase in SOD activity. In this condition, the detoxification capacity evaluated as PP is decreased and is probably related to the high levels of lipid peroxidation.
The THs were significantly lower in the patients than in the control group. This chemical species is a stable intermediate that could generate peroxyl and other ROS by interaction with organic metal.31,32 Generally, in oxidative stress conditions, this index shows higher values because of accumulation of TH. In this case, the lower values could indicate enhanced peroxidation due to an increase in metal concentration that may produce a lipid byproduct such as MDA and 4-HDA. This result needs further corroboration. The hydrophilic antioxidant GSH and the hydrophilic TAS did not show significant changes in the patients.
Two interesting observations were made. The first was the alteration of the redox markers, which probably started before day 3, suggesting an early compromise of the oxidant/antioxidant balance. The second was the increase or decrease in the levels of the studied markers on day 5. This observation was preceded by defervescence at day four in most of the patients. Conversely, thrombocytopenia and hemoconcentration was observed on days 4 and 5 in DHF and DFHM cases, respectively. Unfortunately, we could not collect a convalescent serum sample to evaluate the redox at recovery. However, a tendency to normality was observed in some of the indices. The present results also suggest a higher severity of oxidative stress in DHF patients, but due to the small size of the samples, statistical significance could not be determined.
Few redox diagnostic schedules have been followed during acute infections. As a result, comparisons of altered redox equilibrium associated with acute viral or bactericidal infections are not available. However, a recent investigation compared heme oxygenase-1 (HO-1) production by monocytes in vivo in various acute inflammatory illnesses and in healthy controls.33 Heme oxygenase-1, an inducible heme-degrading enzyme, exerts a potent anti-inflammatory effect through the production of carbon monoxide and bilirubin. Significantly elevated HO-1 mRNA levels seen in acute inflammatory illnesses suggest that monocyte production of HO-1 serves as a potent anti-inflammatory agent in controlling excessive cell or tissue injury in the presence of oxidative stress and cytokinemia.33
Different cells, such as leukocytes and endothelial cells, contribute to ROS production. Specifically, ROS generation has been detected when endothelial cells are stimulated by cytokines,34 a process reported to occur during dengue infection.35 The oxidative stress processes resulting from cytotoxic lipid products may modify proteins and cell membranes. The ROS can attack polyunsaturated fatty acids and initiate lipid peroxidation, a process that can ultimately lead to a loss of membrane function and in some situations alterations in the integrity of the membrane. It has been suggested that the increased vascular permeability observed in DHF is caused by a malfunction rather than a structural destruction of the endothelial cells.4,36 It is possible that also endothelial cells contribute to ROS production during a dengue infection.
The present study suggests the relationship of in vivo oxidative stress, as indicated by high levels of sensitive markers of lipid peroxidation, with the pathogenesis of dengue virus infection. Lipid peroxidation levels and endothelial cell dysfunction could be related and would acutely enhance local or systemic vascular leakage. However, it is necessary to study the kinetic of these markers in a more representative number of DHF serum samples.
Our results will contribute to an integral overview of dengue infection and open a new window for the study of this disease. Further investigations are needed to elucidate the role of redox status in the context of virus replication, T cell activation, and apoptosis.
Received December 19, 2003. Accepted for publication April 27, 2004.
Acknowledgments: We thank Dr. Jean Handy (University of North Carolina, Chapel Hill, NC) and Drs. Ana B. Pérez and Maritza Pupo (Institute of Tropical Medicine Pedro Kouri) for their useful suggestions and comments.
Authors addresses: Lizette Gil and Rolando Tápanes, Department of Clinical Pharmacology, Hospital, Institute of Tropical Medicine Pedro Kourí, Havana, Cuba. Gregorio Martínez, College of Pharmacy and Food, Havana University, Havana, Cuba. Osvaldo Castro and Daniel González, Department of Clinical Care, Hospital, Institute of Tropical Medicine Pedro Kourí, Havana, Cuba. Lidice Bernardo, Susana Vázquez, Gustavo Kourí, and María G. Guzmán, Virology Department, Pan American Health Organization/World Health Organization Collaborating Center for Viral Diseases, Institute of Tropical Medicine Pedro Kourí, PO Box 601, Marianao 13, Ciudad de la Havana, Havana, Cuba, Telephone: 53-7-202-0450 and 53-7-202-0633, Fax: 53-7-204-6051, E-mail: lupe{at}ipk.sld.cu.
| REFERENCES |
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |